Sign in
4

Changes in Ownership

Climb Bio, Inc. Filed Acc 0001231919-25-000616

Director bought 314,561 shares at an average $2.40 ($754,737)

  • Director returned 20,440,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-11 Returned to the company : show line 1 in the form −20,440,000 3,081,757 I
2025-12-11 Purchase : show line 2 in the form +213,099 $2.18 $464,556 3,294,856 I
2025-12-12 Purchase : show line 3 in the form +101,462 $2.86 $290,181 3,396,318 I
Open-market purchases · 314,561 sh · avg $2.40 · $754,737

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-11 Grant or award : show line 4 in the form Pre-Funded Warrants (Right to Buy) +20,440,000 20,440,000 I
Loading xslF345X05/form4-12162025_121255.xml…